Evidence map›Paper›PMID 36207694›Full record

ArticleBMC cancer2022

Modifiable lifestyle factors have a larger contribution to colorectal neoplasms than family history.

Shuyuan Wang, Zhen Yuan, Yuqi Wang, Xuanzhu Zhao, Weifeng Gao, Hongzhou Li, Yuanshun Zhao, Zili Zhang, Shuiqing Liang, Zhaoce Liu and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Shuyuan Wang *School of Medicine, Nankai University, Tianjin, China.
Zhen Yuan *School of Medicine, Nankai University, Tianjin, China.
Yuqi Wang *School of Medicine, Nankai University, Tianjin, China.
Xuanzhu Zhao *Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
Weifeng GaoDepartment of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
Hongzhou LiDepartment of Endoscopy, Tianjin Union Medical Center, Tianjin, China.
Yuanshun ZhaoDepartment of Endoscopy, Tianjin Union Medical Center, Tianjin, China.
Zili ZhangTianjin Third Central Hospital, Tianjin, China.
Shuiqing LiangDagang Hospital of Tianjin Binhai New Area, Tianjin, China.
Zhaoce LiuSchool of Medicine, Nankai University, Tianjin, China.
Qinghuai ZhangDepartment of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
Hong MaDepartment of Nursing, Tianjin Union Medical Center, Tianjin, China.
Xipeng ZhangDepartment of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China. xipengzhangtj@163.com.
Wei CuiSchool of Mathematical Sciences and LPMC, Nankai University, Tianjin, China. weicui@nankai.edu.cn.
Chunze ZhangDepartment of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China. chunze.zhang@nankai.edu.cn.
Nankai University · CNTianjin People's Hospital · CNTianjin Hospital · CNTianjin Third Central Hospital · CNTianjin University of Traditional Chinese Medicine · CNUnion Hospital · CN

Funding

National Key R&D Program of China 2017YFC1700604National Key R&D Program of China 2017YFC1700606Natural Science Foundation of Tianjin 21JCZDJC00060Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-044ATianjin Science and Technology Pillar Program 19YFZCSY00420
6 · The paper itself

Abstract

backgroundScreening recommendations for colorectal cancer (CRC) are mainly based on family history rather than lifestyle risk factors. We aimed to assess and compare risk factors for colorectal neoplasm (CRN) and evaluate trends in neoplasm detection rates during the three rounds of screening from 2012 to 2020 in Tianjin, China.

methodsThis study was based on 89,535 first-recorded colonoscopies in Tianjin CRC screening program, 2012-2020. Of these, 45,380 individuals with complete family history and lifestyle factors were included for population attributable fraction (PAF) estimation.

resultsThe overall detection rate of nonadvanced adenomas, advanced adenomas and CRC was 39.3%, 5.9% and 1.5%, respectively. The PAFs of current smoking, alcohol consumption, physical activity, higher BMI and family history of CRC, respectively, were 8.9%, 2.6%, 1.9%, 5.8%, and 1.1% for males with nonadvanced CRN; 12.3%, 7.3%, 4.9%, 7.2%, and 0.8% for males with advanced CRN; 3.4%, 0.4%, 2.1%, 7.8%, and 0.7% for females with nonadvanced CRN; and 4.3%, 0.2%, 8.2%, 8.5%, and -0.6% for females with advanced CRN. The PAFs of selected lifestyle factors were 19.9% for males with nonadvanced CRN, 29.0% for males with advanced CRN, 9.7% for females with nonadvanced CRN and 13.8% for females with advanced CRN.

conclusionsModifiable lifestyle factors, including smoking, alcohol consumption, physical activity and BMI, have a larger contribution to CRN than family history of CRC. Our findings will provide references for developing guidelines of CRC prevention and control in China.

Indexed as

AdenomaColorectal NeoplasmsColonoscopyFemaleHumansLife StyleMaleRisk FactorsColorectal NeoplasmsPopulation Attributable FractionRisk Factors

Identifiers

PMID36207694
PMCPMC9547467
OpenAlexW4303474398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.